One of the side effects of the COVID-19 pandemic has been a systematic re-evaluation of how cancer care is delivered in the United States. The usage of telehealth appointments in oncology has risen rapidly since March 2020, and recent society guidelines now suggest several strategies for decreasing the frequency of cancer therapy infusions. [1][2][3] Journeying through a global pandemic with a diagnosis of cancer has undoubtedly been stressful for patients and their caregivers, both because of fear of the novel coronavirus itself and also because of uncertainties regarding delays in cancer care. However, one silver lining of the COVID-19 pandemic-borne out of the desire to keep our patients and clinicians safe-has been a renewed emphasis on maximizing how much time patients can spend at home.Author affiliations and support information (if applicable) appear at the end of this article.